Friess Associates’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-35,818
Closed -$11.6M 119
2019
Q4
$11.6M Sell
35,818
-32,695
-48% -$9.91M 0.8% 53
2019
Q3
$20.3M Buy
+68,513
New +$20.2M 1.57% 26
2019
Q1
Sell
-31,714
Closed -$9.25M 137
2018
Q4
$9.25M Buy
+31,714
New +$9.82M 0.79% 55
2018
Q1
Sell
-109,816
Closed -$23.3M 109
2017
Q4
$23.3M Sell
109,816
-247
-0.2% -$50.8K 1.93% 4
2017
Q3
$21.3M Buy
110,063
+6,312
+6% +$1.18M 1.87% 6
2017
Q2
$17.5M Buy
103,751
+3,177
+3% +$550K 1.59% 15
2017
Q1
$16.7M Buy
+100,574
New +$15.8M 1.57% 17

Other funds holding ILMN

Friess Associates's ILMN Position: Q1 2020 in Review

Friess Associates sold out of Illumina (ILMN) in Q1 2020, closing a stake of 35,818 shares — an estimated $11.6M sold.

Friess Associates first reported a position in ILMN in Q1 2017 and held it in 7 quarters. The position peaked at $23.3M in Q4 2017. 825 funds tracked by Wall St. Rank hold ILMN as of Q1 2020.

  • Friess Associates reported no remaining Illumina position as of Q1 2020 after selling out during the quarter.
  • Friess Associates sold 35,818 Illumina shares in Q1 2020, an estimated $11.6M.
  • Friess Associates first reported a position in Illumina in Q1 2017 and held it in 7 quarters.
  • Friess Associates's Illumina position peaked at $23.3M in Q4 2017.
  • 825 funds tracked by Wall St. Rank held Illumina as of Q1 2020.

Based on Friess Associates's 13F filing for Q1 2020, filed 15 May 2020.